Breaking News

Debiopharm Group Plans Expansion

Aims to acquire opportunities for optimization and production of complex drugs

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Debiopharm Group has plans to expand and optimize activities at Debiopharm Research & Manufacturing S.A., its development and production facility in Martigny, Switzerland, through the acquisition of industrial high-value added activities or companies in the pharma, biopharma or medical technology field. Debiopharm Research & Manufacturing provides chemical synthesis, formulation development and manufacturing. The company aims to acquire opportunities for optimization and production of c...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters